
    
      Despite some positive findings from observational and animal studies, the effects of n-3 PUFA
      administration on cognitive impairment in humans have received little evaluation to date.
      Although some clinical trials of fish oil have been reported, the results are inconsistent.
      Given these inconsistent findings, we carried out a preliminary study to investigate the
      effect of fish oil monotherapy on cognitive function and general clinical condition in
      patients with cognitive impairment.
    
  